Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab

BACKGROUND: Recently SARS-CoV-2 has spread worldwide causing a pandemic. Little is known about disease severity in immunocompromised hosts and people receiving disease modifying therapies (DMTs). In the last decades DMTs have been widely employed, and ocrelizumab represents one of the newest therapi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mult Scler Relat Disord
Prif Awduron: Iannetta, Marco, Cesta, Novella, Stingone, Christof, Malagnino, Vincenzo, Teti, Elisabetta, Vitale, Pietro, De Simone, Giuseppe, Rossi, Benedetta, Ansaldo, Lorenzo, Compagno, Mirko, Spalliera, Ilaria, Di Lorenzo, Andrea, Landi, Doriana, Nicoletti, Carolina Gabri, Marfia, Girolama Alessandra, Andreoni, Massimo, Sarmati, Loredana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier B.V. 2020
Pynciau:
Correspondence
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399651/
https://ncbi.nlm.nih.gov/pubmed/32777745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102442
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg